Ligence Reflecting on RSNA 2023: Key Insights

The Radiological Society of North America (RSNA) 2023 marked a pivotal moment in the healthcare industry, and Ligence, a prominent player in the field, took the opportunity to reflect on the transformative trends that emerged. This article delves into key insights gained from RSNA 2023 and sheds light on the dynamic changes influencing the future of healthcare.

 Embracing Collaboration Over White Label

A noticeable paradigm shift was observed at RSNA 2023 – the era of white-label dominance is fading, making room for a collaborative ethos. Picture Archiving and Communication Systems (PACS) are now opening their doors to integrate diverse AI tools, breaking away from the constraints of proprietary branding. The industry is witnessing a strategic move towards fostering cooperation, allowing healthcare solutions to thrive independently of rigid labels.

From Vision to Pragmatism: The ROI Imperative

In the realm of AI solutions for healthcare, the focus has shifted from lofty visions to pragmatic considerations. The pivotal question that now guides decision-makers is no longer about the potential for creating health but a pragmatic one: What’s the Return on Investment (ROI)? The answer to this question is poised to define the pace of adoption and success for healthcare software. RSNA 2023 emphasized the importance of practicality in shaping the future of health tech.

Value-Based Healthcare and the Role of AI

While fee-for-service healthcare models remain resistant to embracing preventive AI solutions, the pendulum is swinging towards value-based healthcare. RSNA discussions highlighted the neglectfulness of fee-for-service models in adopting preventative AI solutions and underscored the increasing alignment with value-based care. The shift towards a proactive approach in healthcare, supported by AI, is gaining momentum, promising a more comprehensive and sustainable healthcare landscape.


RSNA 2023 not only served as a stage for pivotal industry shifts but also as a platform to reconnect with old friends and forge new alliances. Ligence extends gratitude for the warmth and camaraderie experienced at the event. As the healthcare industry continues to evolve, these key insights from RSNA 2023 will undoubtedly shape Ligence’s approach in contributing to the advancement of healthcare technology and collaborative partnerships.

In the ever-evolving landscape of healthcare technology, Ligence remains committed to innovation, collaboration, and a future where AI-driven solutions contribute significantly to improved patient outcomes.

Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

Share the Post:

Related Posts

AI improves the accuracy of echocardiograms, predicts the likelihood of heart attacks and alert clinicians to potential drug interactions or worsening patient conditions.
The British Society of Echocardiography has introduced new, patient-specific algorithms for assessing left ventricular diastolic function. Now, the guidelines offer specific algorithms tailored to three groups.